RP

Robert Peach

Amplia Therapeutics Limited | Non-Executive Director
Dr Peach has over 30 years of drug discovery and development experience in the Pharmaceutical and Biotechnology industry. Dr Peach held senior executive and scientific positions in other companies including Apoptos, Biogen Idec, IDEC and Bristol-Myers Squibb, supporting in-licensing, acquisition and venture investments. His drug discovery and development experience in autoimmune and inflammatory diseases, and cancer has resulted in multiple drugs entering clinical trials and 3 registered drugs. He is also member of Risk Committee.

Company and Role

Company
Title
Tenure
Since
ATX
ATX
Amplia Therapeutics Limited
  • Non-Executive Director
9yrs, 7mthSep 2015

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ATX
ATX
Amplia Therapeutics Limited
20/12/2405,478,9901,350,218N/A
1AD
1AD
30/06/24373,7991,079,3272,950,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Issued
815,218$0.083$67,663As advised by the company
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Issued
1,086,957$0.115$125,000As advised by the company
ATX
ATX
Amplia Therapeutics Limited
19/06/24
Buy
827,268$0.055$45,499Off-market trade
ATX
ATX
Amplia Therapeutics Limited
15/05/24
Issued
1,900,005$0.055$104,500Rights issue
1AD
1AD
19/12/23
Issued
1,750,000$0.013$22,092Issue of options